Hepatitis C therapy in treatment-naı̈ve patients
- 1 December 1999
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 107 (6) , 56-61
- https://doi.org/10.1016/s0002-9343(99)00384-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Sustained virologic response to interferon alpha (IFN-α) in chronic hepatitis C is associated with long-term histologic improvement and lack of hepatic HCV RNAGastroenterology, 1998
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trialsHepatology, 1997
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis CHepatology, 1997
- Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α TherapyAnnals of Internal Medicine, 1997
- Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis CGastroenterology, 1996